Effect of 45nm silver nanoparticles (AgNPs) upon the smooth muscle of rat trachea: Role of nitric oxide

Toxicology Letters

Volumn 207, Issue 3, 2011, Pages 306-313

  González, Carmen ^a,d   Salazar García, Samuel ^a   Palestino, Gabriela ^a   Martínez Cuevas, Pedro P ^a   Ramírez Lee, Manuel A ^a   Jurado Manzano, Brenda B ^a   Rosas Hernández, Héctor ^a   Gaytán Pacheco, Noemí ^b   Martel, Guadalupe ^b   Espinosa Tanguma, Ricardo ^b   Biris, Alexandru S ^c   Ali, Syed F ^d  

^a UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

^c UNIVERSITY OF ARKANSAS AT LITTLE ROCK   (United States)

^d NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Acetylcholine; Hyper reactivity; NO; Silver nanoparticles; Trachea

Indexed keywords

ACETYLCHOLINE; ATROPINE; MUSCARINIC RECEPTOR; NITRIC OXIDE; SILVER NANOPARTICLE; METAL NANOPARTICLE; SILVER;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE; SMOOTH MUSCLE CONTRACTILITY; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE TONE; TOXICITY TESTING; TRACHEA MUSCLE; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING; ANIMAL; CHEMISTRY; DRUG EFFECT; DRUG INTERACTION; MALE; MUSCLE CONTRACTION; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TRACHEA;

RATTUS;

ACETYLCHOLINE; ANIMALS; BLOTTING, WESTERN; DRUG INTERACTIONS; MALE; METAL NANOPARTICLES; MICROSCOPY, ELECTRON, TRANSMISSION; MUSCLE CONTRACTION; MUSCLE, SMOOTH; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; SILVER; TRACHEA;

EID: 80054711095     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2011.09.024     Document Type: Article

References (32)

1. Algara-Suárez P., Romero-Méndez C., Chrones T., et al. Functional coupling between the Na/Ca exchanger and nonselective cation channels during histamine stimulation in guinea pig tracheal smooth muscle. Am. J. Physiol. Lung Cell Mol. Physiol. 2007, 293(1):L191-L198.
2. Antošová M., Strapková A., Nosáľová G., et al. Effect of nitric oxide synthases inhibitors on exogenous irritant-induced bronchial hyper-reactivity in guinea pigs. Gen. Physiol. Biophys. 2006, 25(2):137-147.
3. Bonner J.C. Nanoparticles as a potential cause of pleural and interstitial lung disease. Proc. Am. Thorax Soc. 2010, 7(2):138-141.
4. Brook R.D., Franklin B., Casio W., et al. Air pollution and cardiovascular disease: a statement for health-care professionals from the expert panel on population and prevention science of the American Heart Association. Circulation 2004, 109:2655-2671.
5. Chen X., Schluesener H.J. Nanosilver: a nanoproduct in medical application. Toxicol. Lett. 2008, 176(1):1-12.
6. Courtois A., Andujar P., Ladeiro Y., et al. Impairment of NO-dependent relaxation in intralobular pulmonary arteries: comparison of urban particulate matter and manufactured nanoparticles. Environ. Health Perspect. 2008, 116(10):1294-1299.
7. Creighton J.A., Blatchford C.G., Albrecht M.G. Plasma resonance enhancement of Raman scattering by pyridine adsorbed on silver or gold sol particles of size comparable to the excitation wavelength. J. Chem. Soc., Faraday Trans. 2 1979, 75:790-798.
8. Eglen R.M. Muscarinic receptor subtypes in neuronal and non-neuronal cholinergic function. Auton. Autacoid Pharmacol. 2006, 26(3):219-233.
9. Español A.J., Goren N., Ribeiro M.L., et al. Nitric oxide synthase I and cyclooxigenase-2 enzymes are targets of muscarinic activation in normal and inflamed NIH3T3 cells. Inflamm. Res. 2010, 59(3):227-238.
10. Exton J.H. Regulation of phosphoinositide phospholipases by hormones, neurotransmitters, and other agonists linked to G proteins. Annu. Rev. Pharmacol. Toxicol. 1996, 36:481-509.
11. Foldbjerg R., Dang D.A., Autrup H. Cytotoxicity and genotoxicity of silver nanoparticles in the human cancer cell line, A549. Arch. Toxicol. 2011, 85(7):743-750.
12. Guo F.H., Raeve H.R., Rice T.W., et al. Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal airway epithelium in vivo. Proc. Natl. Acad. Sci. U.S.A. 1995, 92(17):7809-7813.
13. Hasaneen N.A., Foda H.D., Said S.I. Nitric oxide and vasoactive intestinal peptide as co-transmitters of airway smooth-muscle relaxation: analysis in neuronal nitric oxide synthase knockout mice. Chest 2003, 124(3):1067-1072.
14. Huang A.L., Vita J.A. Effects of systemic inflammation on endothelium-dependent vasodilation. Trends Cardiovascular Med. 2006, 16:15-20.
15. Hussain S.M., Schlager J. Safety evaluation of silver nanoparticles: inhalation model for chronic exposure. Toxicol. Sci. 2009, 108(2):223-224.
16. Ji J.H., Jung J.H., Kim S.S., et al. Twenty-eight-day inhalation toxicity study of silver nanoparticles in Sprague-Dawley rats. Inhal. Toxicol. 2007, 19(10):857-871.
17. Kelm M., Schrader J. Nitric oxide release from the isolated guinea pig heart. Eur. J. Pharmacol. 1988, 155(3):317-321.
18. Kim Y.S., Song M.Y., Park J.D., et al. Subchronic oral toxicity of silver nanoparticles. Particle Fibre Toxicol. 2010, 7:20.
19. Kummer W., Lips K.S., Pfeil U. The epithelial cholinergic system of the airways. Histochem. Cell Biol. 2008, 130(2):219-234.
20. Liao D., Creason J., Shy C., et al. Daily variation of particulate air pollution and poor cardiac autonomic control in the elderly. Environ. Health Perspect. 1999, 107(7):521-525.
21. Nemmar A., Hoet P.H., Vanquickenborne B., et al. Passage of inhaled particles into the blood circulation in humans. Circulation 2002, 105(4):411-414.
22. Nurkiewicz T.R., Porter D.W., Berger M., et al. Systemic microvascular dysfunction and inflammation after pulmonary particulate matter exposure. Environ. Health Perspect. 2006, 114(3):412-419.
23. Prado C.M., Leick-Maldonado E.A., Yano L., et al. Effects of nitric oxide synthases in chronic allergic airway inflammation and remodeling. Am. J. Respir. Cell Mol. Biol. 2006, 35(4):457-464.
24. Ricciardolo F.L., Maria D.G.U., Mistretta A. Impairment of bronchoprotection by nitric oxide in severe asthma. Lancet 1997, 350(9087):1297-1298.
25. Ricciardolo F.L.M., Sterk P.J., Gaston B., et al. Nitric oxide in health and disease of the respiratory system. Physiol. Rev. 2004, 84(3):731-765.
26. Rodríguez-Manzo J.A., Terrones M., Terrones H., et al. In situ nucleation of carbon nanotubes by the injection of carbon atoms into metal particles. Nat. Nanotechnol. 2007, 2(5):307-311.
27. Rosas-Hernández H., Jiménez-Badillo S., Martínez-Cuevas P.P., et al. Effects of silver nanoparticles (Ag-45nm) upon coronary endothelial cells and isolated aortic rings. Toxicol. Lett. 2009, 191(2-3):305-313.
28. Seaton A., MacNee W., Donaldson K., et al. Particulate air pollution and acute health effects. Lancet 1995, 345:176-178. 8943.
29. Slistan-Grijalva A., Herrera-Urbina R., Rivas-Silva J.F., et al. Classical theoretical characterization of the surface plasmon absorption band for silver spherical nanoparticles suspended in water and ethylene glycol. Physica E: Low-dimension Syst. Nanostruct. 2005, 27(1-2):104-112.
30. Sung J.H., Ji J.H., Park J.D., et al. Subchronic inhalation toxicity of silver nanoparticles. Toxicol. Sci. 2009, 108(2):452-461.
31. Sung J.H., Ji J.H., Yoon J.U., et al. Lung function changes in Sprague-Dawley rats after prolonged inhalation exposure to silver nanoparticles. Inhal. Toxicol. 2008, 20(6):567-574.
32. Yamawaki H., Iwai N. Mechanisms underlying nano-sized air-pollution-mediated progression of atherosclerosis: carbon black causes cytotoxic injury/inflammation and inhibits cell growth in vascular endothelial cells. Circ. J. 2006, 70(1):129-140.